Reviva Pharmaceuticals (RVPH) Institutional Ownership $1.22 -0.04 (-3.19%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$6.23MNumber ofInstitutional Sellers(last 12 months)0 Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382% 5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 4/28/2021 DAVENPORT & Co LLC15,000$86K0.0%N/A0.162% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, the following institutional investors and hedge funds held shares of Reviva Pharmaceuticals shares: Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), EMC Capital Management ($613K), Geode Capital Management LLC ($401K), Virtu Financial LLC ($108K), Tang Capital Management LLC ($103K), and Wolverine Asset Management LLC ($85K).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? The following institutional investors have purchased Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($1.16M), EMC Capital Management ($183.87K), Geode Capital Management LLC ($42.38K), Vanguard Group Inc. ($26.85K), Tang Capital Management LLC ($24.13K), Virtu Financial LLC ($18.45K), and Wolverine Asset Management LLC ($14.55K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 1,488,220 shares in the last 24 months. This purchase volume represents approximately $7.37M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($224K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 224,000 shares in the last 24 months. This volume of shares sold represents approximately $1.09M in transactions. Related Companies TSVT Major Shareholders DRUG Major Shareholders FULC Major Shareholders GOSS Major Shareholders ATOS Major Shareholders OGI Major Shareholders ELDN Major Shareholders CKPT Major Shareholders BDTX Major Shareholders IVA Major Shareholders This page (NASDAQ:RVPH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.